What Is the Wolverine Blend?
The Wolverine Blend is a two-peptide research compound that combines BPC-157 (10mg), a synthetic pentadecapeptide derived from a protective protein in human gastric juice, with TB-500 (10mg), a synthetic fragment of the naturally occurring protein Thymosin beta-4. Both are among the most frequently studied peptides in preclinical tissue-repair research.
The pairing is designed to target complementary regenerative pathways: BPC-157's cytoprotective and vascular signaling alongside TB-500's actin-regulating and pro-angiogenic activity. The combination is the two-peptide repair core shared by the larger Glow and KLOW blends. Both components are research compounds, and neither is an approved drug.
Peptide Profile
Product: Wolverine Blend (two-peptide research compound)
Components: BPC-157 10mg · TB-500 10mg
BPC-157: 15-residue peptide (Body Protection Compound), ~1,419 Da
TB-500: synthetic peptide based on the actin-binding region of Thymosin beta-4 (a 43-residue, ~4,921 Da protein)
Classification: Tissue-repair and recovery research blend
Mechanism of Action
The Wolverine blend pairs two peptides whose mechanisms overlap in tissue repair while approaching it through different molecular routes.
BPC-157: Cytoprotection & Vascular Signaling
BPC-157 is a 15-amino-acid sequence derived from a protective protein isolated from human gastric juice. Preclinical research has described angiogenic effects, modulation of the nitric oxide system, and accelerated repair of soft tissues including tendon, ligament, muscle, and gastrointestinal mucosa, making it one of the most studied peptides in the tissue-repair literature.
TB-500: Actin Sequestration & Cell Migration
TB-500 is a synthetic fragment of Thymosin beta-4, a protein involved in cell migration, differentiation, and wound repair. Its primary mechanism is actin sequestration, which regulates cell motility and enables tissue regeneration.
TB-500: Angiogenesis & Recovery
Beyond actin regulation, research has described TB-500 promoting new blood-vessel formation, reducing inflammation, and accelerating recovery in models of soft-tissue injury, skin wounds, and cardiac stress, contributing a vascular and anti-inflammatory dimension that complements BPC-157.
Complementary Repair Pathways
BPC-157 and TB-500 operate through different but overlapping mechanisms, cytoprotective and vascular signaling on one side and actin-based cell migration and angiogenesis on the other. Stacked research protocols investigate whether combining these signals produces broader regenerative coverage than either peptide alone.
Research Overview
Both Wolverine components have extensive preclinical literature in tissue repair. The table summarizes key research areas across the two peptides.
| Research Area | Key Findings | Study Type |
|---|---|---|
| Tendon & Ligament (BPC-157) | Studies describe accelerated healing of transected tendon and enhanced tendon-cell outgrowth and migration in rodent models | In vivo & in vitro (rodent) |
| Gastrointestinal (BPC-157) | Research documents cytoprotective effects on gastric and intestinal mucosa across a range of injury models | In vivo (rodent) |
| Vascular / Angiogenesis (BPC-157) | Preclinical studies describe promotion of new blood-vessel formation and improved blood flow in healing tissue | In vitro & in vivo |
| Wound Healing (TB-500) | Thymosin beta-4 accelerated wound closure and dermal repair in preclinical wound models | In vivo (rodent) |
| Cardiac Repair (TB-500) | Research described Thymosin beta-4 promoting cardiac cell migration, survival, and repair, and epicardial progenitor mobilization | In vivo (mouse) |
| Cell Migration (TB-500) | Actin sequestration by Thymosin beta-4 enhanced cell migration and regeneration in soft-tissue models | In vitro & in vivo |
BPC-157 and TB-500 each have substantial preclinical records, but the Wolverine combination itself has not been studied as a formulation; the evidence base is the sum of the two components' individual literature. Both are studied almost entirely in animal and in vitro models, and human clinical data are limited.
Common Areas of Research Interest
Research interest in the Wolverine components centers on soft-tissue repair and recovery.
- Soft-tissue and tendon repair, the shared core research interest of both BPC-157 and TB-500
- Angiogenesis and vascular signaling, promotion of new blood-vessel formation in healing tissue
- Wound healing, accelerated closure and dermal repair in preclinical models
- Muscle and connective-tissue recovery, the applied research context for the pairing
- Cardiac and organ repair, a distinct TB-500 (Thymosin beta-4) research thread
- Combined regenerative research, interest in whether complementary signals broaden regenerative coverage
Comparison to Related Blends
Wolverine is the two-peptide repair core that the larger Glow and KLOW blends build upon.
| Feature | Wolverine | Glow Blend | KLOW Blend |
|---|---|---|---|
| Components | BPC-157, TB-500 | GHK-Cu, BPC-157, TB-500 | GHK-Cu, BPC-157, TB-500, KPV |
| Primary Focus | Soft-tissue repair and recovery | Skin remodeling and repair | Skin, repair, and inflammation |
| Copper-Peptide Arm | None | GHK-Cu | GHK-Cu |
| Anti-Inflammatory Arm | Indirect (BPC-157/TB-500) | Indirect (BPC-157/TB-500) | Explicit (KPV) |
| Peptide Count | 2 | 3 | 4 |
Frequently Asked Questions
Sources & References
- Chang CH, Tsai WC, Lin MS, et al. "The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration." J Appl Physiol (1985). 2011;110(3):774-80. PubMed
- Sikiric P, Seiwerth S, Rucman R, et al. "Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract." Curr Pharm Des. 2011;17(16):1612-32. PubMed
- Malinda KM, Sidhu GS, Mani H, et al. "Thymosin beta4 accelerates wound healing." J Invest Dermatol. 1999;113(3):364-8. PubMed
- Goldstein AL, Hannappel E, Kleinman HK. "Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues." Trends Mol Med. 2005;11(9):421-9. PubMed
- Bock-Marquette I, Saxena A, White MD, et al. "Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair." Nature. 2004;432(7016):466-72. PubMed
- Smart N, Risebro CA, Melville AA, et al. "Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization." Nature. 2007;445(7124):177-82. PubMed
Explore the Wolverine Blend
Available for research purposes. Third-party tested for purity and identity.
View Wolverine Blend — $150This product is intended for research and laboratory use only. It is not intended for human consumption.